o
|
Preliminary
Proxy Statement
|
o
|
Confidential,
for Use of the Commission Only
|
|
x
|
Definitive
Proxy Statement
|
(as
permitted by Rule 14a-6(e)(2))
|
||
o
|
Definitive
Additional Materials
|
|||
o
|
Soliciting
Material Pursuant to Rule 14a-11(c) or
Rule 14a-12
|
x
|
No
fee required.
|
o
|
Fee
computed on table below per Exchange Act Rules 14a-6(i)(4) and
0-11.
|
(1)
|
Title
of each class of securities to which transaction applies:
N/A
|
(2)
|
Aggregate
number of securities to which transaction applies:
N/A
|
(3)
|
Per
unit price or other underlying value of transaction computed pursuant
to
Exchange Act Rule 0-11 (Set forth the amount on which the filing
fee is
calculated and state how it was determined):
N/A
|
(4)
|
Proposed
maximum aggregate value of transaction:
N/A
|
(5)
|
Total
fee paid: $0
|
o
|
Fee
paid previously with preliminary materials:
N/A
|
o
|
Check
box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting fee
was paid previously. Identify the previous filing by registration
statement number, or the Form or Schedule and the date of its
filing.
|
(1)
|
Amount
Previously Paid:
|
(2)
|
Form,
Schedule or Registration Statement
No.:
|
(3)
|
Filing
Party:
|
(4)
|
Date
Filed:
|
1.
|
To
elect nine directors to serve until the next Annual General Meeting
of
Shareholders;
|
2.
|
To
receive and adopt the financial statements of the Company for the
Company’s fiscal year ended December 31, 2005, together with the auditors’
report thereon; and
|
3.
|
To
appoint Deloitte & Touche LLP as the independent registered public
accounting firm for the Company in respect of the fiscal year ended
December 31, 2006 and to authorize the Board Directors, acting through
the
Audit Committee, to approve their
fee.
|
By
order of the Board of Directors,
|
||
/s/ Daniel Penn | ||
DANIEL
PENN
|
||
Secretary
|
Beneficial
Ownership of
Class
A Common
Stock(a)
|
Beneficial
Ownership of
Class
B Common
Stock
|
Common
Stock
|
|||||||||||||||||
Name
of Beneficial Owner
|
Number
|
Percent
|
Number
|
Percent
|
%
of
Voting
Power(b)
|
%
Owner-ship(b)
|
|||||||||||||
Ronald
S. Lauder(1)(8)
|
*
|
*
|
6,040,365(24)
|
|
85.04%
|
|
57.72%
|
|
14.83%
|
|
|||||||||
Michael
N. Garin
|
80,000(12)
|
|
*
|
--
|
--
|
*
|
*
|
||||||||||||
Charles
R. Frank, Jr.
|
6,400(13)
|
|
*
|
--
|
--
|
*
|
*
|
||||||||||||
Herbert
A. Granath
|
26,400(14)
|
|
|
--
|
--
|
|
|
||||||||||||
Frederic
T. Klinkhammer (2)
|
14,000(15)
|
|
*
|
--
|
--
|
*
|
*
|
||||||||||||
Herbert
Kloiber (3)
|
*
|
*
|
--
|
--
|
*
|
*
|
|||||||||||||
Alfred
W. Langer
|
20,800(16)
|
|
*
|
--
|
--
|
*
|
*
|
||||||||||||
Bruce
Maggin
|
13,600(17)
|
|
*
|
--
|
--
|
*
|
*
|
||||||||||||
Ann
Mather
|
4,000(18)
|
|
--
|
--
|
--
|
--
|
--
|
||||||||||||
Eric
Zinterhofer
|
4,000(19)
|
|
--
|
--
|
--
|
--
|
--
|
||||||||||||
|
|
|
|
|
|||||||||||||||
Robert
E. Burke
|
175,000(20)
|
|
*
|
--
|
--
|
*
|
*
|
||||||||||||
Wallace
Macmillan
|
33,332(21)
|
|
*
|
--
|
--
|
*
|
*
|
||||||||||||
Marina
Williams
|
6,666(22)
|
|
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
||||||||||||||
All
directors and executive officers as a group (13 persons)
|
384,198(23)
|
|
1.11%
|
|
6,040,365(23)
|
|
85.04%
|
|
57.88%
|
|
15.63%
|
|
|||||||
|
|
|
|
|
|
||||||||||||||
|
|
|
--
|
--
|
|
|
|||||||||||||
Leonard
A. Lauder(4)(9)
|
--
|
--
|
721,673
|
10.36%
|
|
6.99%
|
|
1.78%
|
|
||||||||||
Federated
Investors, Inc.(5)(10)
|
3,002,788
|
8.93%
|
|
--
|
--
|
2.91%
|
|
7.40%
|
|
||||||||||
Eric
Semler(6)(11)
|
2,365,497
|
7.03%
|
|
--
|
--
|
2.29%
|
|
5.83%
|
|
||||||||||
|
|
|
--
|
--
|
|
||||||||||||||
Testora
Ltd (7)
|
3,500,000
|
10.41%
|
|
--
|
--
|
3.39%
|
|
8.62%
|
|
*
|
Less
than 1.0%
|
(a)
|
Does
not include 6,966,533 shares of Class A Common Stock issuable upon
conversion of shares of Class B Common Stock. Shares of Class B Common
Stock are convertible at any time into shares of Class A Common Stock
for
no additional consideration on a share-for-share
basis.
|
(b)
|
Represents
the percentage of total voting power and the percentage ownership
of the
Class A Common Stock and the Class B Common Stock currently beneficially
owned by each identified shareholder and all directors and executive
officers as a group. The Class A Common Stock and the Class B Common
Stock
are the only authorized classes of the Company’s capital stock with shares
outstanding.
|
(1)
|
The
address of Ronald S. Lauder is Suite 4200, 767 Fifth Avenue, New
York, New
York 10153.
|
(2)
|
Mr.
Klinkhammer’s term as Vice Chairman and a member of the Board of Directors
ended on March 22, 2005 in connection with the expiration of his
employment agreement.
|
(3)
|
Herbert
G. Kloiber was appointed to the Board of Directors on February 1,
2006.
|
(4)
|
Information
in respect of the beneficial ownership of Leonard A. Lauder (other
than
percentage ownership) is based upon a statement on Schedule 13D filed
by
him. The address of Mr. Leonard Lauder is c/o The Estée Lauder Companies
Inc., 767 Fifth Avenue, New York, New York
10153.
|
(5)
|
Information
in respect of the beneficial ownership of Federated Investors, Inc.
(other
than percentage ownership) is based upon a statement on Schedule
13G/A
filed on February 14, 2006 jointly by Federated Investors, Inc.,
Voting
Shares Irrevocable Trust, John F. Donahue, Rhodora J. Donahue and
J.
Christopher Donahue. The address of Federated Investors, Inc., Voting
Shares Irrevocable Trust, John F. Donahue, Rhodora J. Donahue and
J.
Christopher Donahue is Federated Investors Tower, Pittsburgh, Pennsylvania
15222-3779.
|
(6)
|
Information
in respect of the beneficial ownership of Eric Semler (other than
percentage ownership) is based upon a statement on Schedule 13G/A
filed by
him on January 18, 2006. The address of Mr. Semler is 888 Seventh
Avenue,
Suite 1504, New York, New York
10019.
|
(7)
|
Information
in respect of the beneficial ownership of Testora Limited (other
than
percentage ownership) is based upon a statement on Schedule 13G filed
by
it on January 11, 2006. The address of Testora Limited is Grigori
Afxentiou, 8, El.Pa. Livadioti, Flat/Office 401, P.C. 6023, Larnaca,
Cyprus.
|
(8)
|
57,799
of the shares of Class B Common Stock listed are owned directly by
Ronald
S. Lauder, 3,385,417 of the shares of Class B Common Stock are owned
by
RSL Investments Corporation, 1,672,500 of the shares of Class B Common
Stock are owned by RSL Capital LLC and 577,788 of the shares of Class
B
Common Stock are owned by TV Holdings Ltd. , all of which are owned
by Mr.
Lauder. 210,461 of the shares of Class B Common Stock are held by
RAJ
Family Partners L.P., which Mr. Lauder may be deemed to beneficially
own.
In addition Mr. Lauder directly owns currently exercisable options
to
purchase 136,400 shares of Class B Common
Stock.
|
(9)
|
285,239
of the shares of Class B Common Stock listed are owned directly by
Leonard
A. Lauder and 436,434 of the shares of Class B Common Stock are held
by
LWG Family Partners L.P., a partnership whose managing partner is
a
corporation which is one-third owned by Mr.
Lauder.
|
(10)
|
Federated
Investors, Inc. (“Parent”) is the parent holding company of Federated
Equity Management Company of Pennsylvania and Federated Global Investment
Management Corp. (the “Investment Advisors”), which act as investment
advisors to registered investment companies and separate accounts
that own
shares of common stock in Central European Media Enterprises Ltd.
The
Investment Advisors are wholly owned subsidiaries of FII Holdings,
Inc.,
which is a wholly owned subsidiary of Parent. All of the Parent’s
outstanding voting stock is held in the Voting Shares Irrevocable
Trust
for which John F. Donahue, Rhodora J. Donahue and J. Christopher
Donahue
act as trustees. The trustees have collective voting control over
the
Parent and shared voting power over the shares
listed.
|
(11)
|
Mr.
Semler has sole power to vote and to dispose of these shares which
consists of (i) 1,459,491 Shares held for the account of TCS Capital
Investments; (ii) 123,405 Shares held for the account of TCS Capital;
(iii) 780,601 Shares held for the account of TCS Capital II; and
(iv)
2,000 Shares held for the account of TCS Select. TCS Capital Management,
LLC, a Delaware limited liability company (“TCS Capital Management”) is
the investment manager of each TCS Capital International, TCS Capital
and
TCS Capital II. Mr. Semler is the investment manager of TCS Capital
Management.
|
(12)
|
Consists
of 80,000 shares of Class A Common Stock underlying options which
are
currently exercisable at an exercise price of $19.49 per share and
which
expire on February 1, 2014. Does not include (i) 80,000 shares of
Class A
Common Stock underlying options with an exercise price of $19.49
per share
which are not currently exercisable and will not become exercisable
within
60 days and expire on February 1, 2014; and (ii) 30,000 shares of
Class A
Common Stock underlying options with an exercise price of $44.50
per share
which are not currently exercisable and will not become exercisable
within
60 days and expire on June 1, 2015.
|
(13)
|
Consists
of (i) 3,200 shares of Class A Common Stock underlying options which
are
currently exercisable, or will become exercisable within 60 days,
at an
exercise price of $1.958 per share and which expire on May 15, 2012;
and
(ii) 3,200 shares of Class A Common Stock underlying options which
are
currently exercisable, or will become exercisable within 60 days,
at an
exercise price of $10.897 per share and which expire on May 21, 2013.
Does
not include (i) 3,200 shares of Class A Common Stock underlying options
with an exercise price of $1.958 per share which are not currently
exercisable and will not become exercisable within 60 days and expire
on
May 15, 2012; (ii) 6,400 shares of Class A Common Stock underlying
options
with an exercise price of $10.897 per share which are not currently
exercisable and will not become exercisable within 60 days and expire
on
May 21, 2013; (iii) 12,000 shares of Class A Common Stock underlying
options with an exercise price of $22.11 per share which are not
currently
exercisable and will not become exercisable within 60 days and expire
on
June 1, 2014; and (iv) 6,000 shares of Class A Common Stock underlying
options with an exercise price of $44.50 per share which are not
currently
exercisable and will not become exercisable within 60 days and expire
on
June 1, 2015.
|
(14)
|
Consists
of (i) 12,800 shares of Class A Common Stock underlying options which
are
currently exercisable, or will become exercisable within 60 days,
at an
exercise price of $1.958 per share and which expire on May 15, 2012;
(ii)
9,600 shares of Class A Common Stock underlying options which are
currently exercisable, or will become exercisable within 60 days,
at a
price of $10.897 per share and which expire on May 21, 2013; and
(iii)
4,000 shares of Class A Common Stock underlying options which are
currently exercisable, or will become exercisable within 60 days,
at an
exercise price of $22.11 per share and which expire on June 1, 2014.
Does
not include (i) 3,200 shares of Class A Common Stock underlying options
with an exercise price of $1.958 per share are not currently exercisable
and will not become exercisable within 60 days and expire on May
15, 2012;
(ii) 6,400 shares of Class A Common Stock underlying options with
an
exercise price of $10.897 per share which are not currently exercisable
and will not become exercisable within 60 days and expire on May
21, 2013;
(iii) 12,000 shares of Class A Common Stock underlying options with
an
exercise price of $22.11 per share which are not currently exercisable
and
will not become exercisable within 60 days and expire on June 1,
2014; and
(iv) 6,000 shares of Class A Common Stock underlying options with
an
exercise price of $44.50 per share which are not currently exercisable
and
will not become exercisable within 60 days and expire on June 1, 2015.
|
(15)
|
Consists
of 14,000 shares of Class A Common Stock underlying options which
are
currently exercisable or will become exercisable within 60 days,
at an
exercise price of $10.365 per share and which expire on May 28, 2013.
|
(16)
|
Consists
of (i) 4,000 shares of Class A Common Stock underlying options which
are
currently exercisable, or will become exercisable within 60 days,
at an
exercise price of $0.294 per share and which expire on April 18,
2011;
(ii) 6,400 shares of Class A Common Stock underlying options which
are
currently exercisable, or will become exercisable within 60 days,
at an
exercise price of $1.958 per share and which expire on May 15, 2012;
(iii)
6,400 shares of Class A Common Stock underlying options which will
become
exercisable within 60 days, at an exercise price of $10.897 per share
and
which expire on May 21, 2013; and (iv) 4,000 shares of Class A Common
Stock underlying options which are currently exercisable, or will
become
exercisable within 60 days, at an exercise price of $22.11 per share
and
which expire on June 1, 2014. Does not include (i) 3,200 shares of
Class A
Common Stock underlying options with an exercise price of $1.958
per share
which are not currently exercisable and will not become exercisable
within
60 days and expire on May 15, 2012; (ii) 6,400 shares of Class A
Common
Stock underlying options with an exercise price of $10.897 per share
which
are not currently exercisable and will not become exercisable within
60
days and expire on May 21, 2013; (iii) 12,000 shares of Class A Common
Stock underlying options with an exercise price of $22.11 per share
which
are not currently exercisable and will not become exercisable within
60
days, and expire on June 1, 2014; and (iv) 6,000 shares of Class
A Common
Stock underlying options with an exercise price of $44.50 per share
which
are not currently exercisable and will not become exercisable within
60
days and expire on June 1, 2015.
|
(17)
|
Consists
of (i) 9,600 shares of Class A Common Stock underlying options which
are
currently exercisable, or will become exercisable within 60 days,
at an
exercise price of $10.897 per share and which expire on May 21, 2013;
and
(ii) 4,000 shares of Class A Common Stock underlying options which
are
currently exercisable at, or will become exercisable within 60 days,
an
exercise price of $22.11 per share and which expire on June 1, 2014.
Does
not include (i) 6,400 shares of Class A Common Stock underlying options
with an exercise price of $10.897 per share which are not currently
exercisable and will not become exercisable within 60 days and expire
on
May 21, 2013; (ii) 12,000 shares of Class A Common Stock underlying
options with an exercise price of $22.11 per share which are not
currently
exercisable and will not become exercisable within 60 days and expire
on
June 1, 2014; and (iii) 6,000 shares of Class A Common Stock underlying
options with an exercise price of $44.50 which are not currently
exercisable and will not become exercisable within 60 days and expire
on
June 1, 2015.
|
(18)
|
Consists
of 4,000 shares of Class A Common Stock underlying options which
are
currently exercisable, or will become exercisable within 60 days,
at a
price of $22.11 per share and which expire on June 1, 2014. Does
not
include (i) 12,000 shares of Class A Common Stock underlying options
with
an exercise price of $22.11 per share which are not currently exercisable
and will not become exercisable within 60 and expire on June 1, 2014;
and
(ii) 6,000 shares of Class A Common Stock underlying options with
an
exercise price of $44.50 per share which are not currently exercisable
and
will not become exercisable within 60 days and expire on June 1,
2015.
|
(19)
|
Consists
of 4,000 shares of Class A Common Stock underlying options which
are
currently exercisable, or will be exercisable within 60 days, at
a price
of $22.11 per share and which expire on June 1, 2014. Does not include
(i)
12,000 shares of Class A Common Stock underlying options with an
exercise
price of $22.11 per share which are not currently exercisable and
will not
become exercisable within 60 days and expire on June 1, 2014; and
(ii)
6,000 shares of Class A Common Stock underlying options with an exercise
price of $44.50 per share which are not currently exercisable and
will not
become exercisable within 60 days and expire on June 1,
2015.
|
(20)
|
Consists
of (i) 95,000 shares of Class A Common Stock underlying options which
are
currently exercisable at an exercise price of $2.1375 per share and
which
expire on April 1, 2012; and (ii) 80,000 shares of Class A Common
Stock
underlying options which are currently exercisable, or will become
exercisable within 60 days, at an exercise price of $10.365 per share
and
which expire on May 28, 2013. Does not include 15,000 shares of Class
A
Common Stock underlying options with an exercise price of $44.50
per share
which are not currently exercisable and will not become exercisable
within
60 days and expire on June 1, 2015.
|
(21)
|
Consists
of (i) 20,000 shares of Class A Common Stock underlying options which
are
currently exercisable, or will become exercisable within 60 days,
at an
exercise price of $10.365 per share and which expire on May 21, 2013;
and
(ii) 13,332 shares of Class A Common Stock underlying options which
are
currently exercisable, or will become exercisable within 60 days,
at an
exercise price of $18.93 per share and which expire on May 4, 2014.
Does
not include (i) 6,668 shares of Class A Common Stock underlying options
with an exercise price of $18.93 per share which are not currently
exercisable and will not become exercisable within 60 days and expire
on
May 4, 2014; and (ii) 10,000 shares of Class A Common Stock underlying
options with an exercise price of $44.50 per share which are not
currently
exercisable and will not become exercisable within 60 days and which
expire on June 1, 2015.
|
(22)
|
Consists
of 6,666 shares of Class A Common Stock underlying options which
are
currently exercisable, or will become exercisable within 60 days,
at an
exercise price of $32.80 per share and which expire on November 21,
2014.
Does not include (i) 13,334 shares of Class A Common Stock underlying
options with an exercise price of $32.80 per share which are not
currently
exercisable and will not become exercisable within 60 days and expire
on
November 21, 2014; and (ii) 15,000 shares of Class A Common Stock
underlying options with an exercise price of $44.50 per share and
which
are not currently exercisable and will not become exercisable within
60
days and expire on June 1, 2015.
|
(23)
|
Consists
of 384,198 shares of Class A Common Stock underlying options which
are
currently exercisable or will become exercisable within 60 days.
Does not
include 313,202 shares of Class A Common Stock underlying options
which
are not currently exercisable and will not become exercisable within
60
days.
|
(24)
|
Includes
(i) 100,000 shares of Class B Common Stock underlying options which
are
currently exercisable at an exercise price of $23.925 per share and
which
expire on August 1, 2007; (ii) 10,000 shares of Class B Common Stock
underlying options which are currently exercisable, or will become
exercisable within 60 days, at a price of $0.2625 per share and which
expire on May 18, 2011; (iii) 12,800 shares of Class B Common Stock
underlying options which are currently exercisable, or will become
exercisable within 60 days, at a price of $2.0558 per share and which
expire on May 15, 2012; (iv) 9,600 shares of Class B Common Stock
underlying options which will become exercisable within 60 days,
at a
price of $11.44 per share and which expire on May 21, 2013; and (v)
4,000
shares of Class B Common Stock underlying options which are currently
exercisable, or will become exercisable within 60 days, at an exercise
price of $23.22 per share and which expire on June 1, 2014. Does
not
include (i) 3,200 shares of Class B Common Stock underlying options
with
an exercise price of $2.0558 per share which are not currently exercisable
and will not become exercisable within 60 days, and expire on May
15,
2012; (ii) 6,400 shares of Class B Common Stock underlying options
with an
exercise price of $11.44 per share which are not currently exercisable
and
will not become exercisable within 60 days, and expire on May 21,
2013;
(iii) 12,000 shares of Class B Common Stock underlying options with
an
exercise price of $23.22 per share which are not currently exercisable
and
will not become exercisable within 60 days, and expire on June 1,
2014;
and (iv) 6,000 shares of Class B Common Stock underlying options
with an
exercise price of $46.725 which are not currently exercisable and
will not
become exercisable within 60 days and expire on June 1, 2015.
|
Name
of Nominee
|
Principal
Occupation
|
Age
|
Year Became
a Director
|
|||
Ronald
S. Lauder
|
Non-executive
Chairman of the Board
|
62
|
1994
|
|||
Michael
Garin
|
Chief
Executive Officer and Director
|
59
|
2003
|
|||
Charles
R. Frank, Jr.
|
Financial
Advisor
|
68
|
2001
|
|||
Herbert
A. Granath
|
Chairman
Emeritus, ESPN
|
77
|
2002
|
|||
Herbert
Kloiber
|
Chairman,
Telemuenchen Group
|
58
|
2006
|
|||
Alfred
W. Langer
|
Consultant
|
55
|
2000
|
|||
Bruce
Maggin
|
Principal,
the H.A.M. Media Group, LLC
|
62
|
2002
|
|||
Ann
Mather
|
Former
CFO, Pixar Animation Studios
|
46
|
2004
|
|||
Eric
Zinterhofer
|
Partner,
Apollo Management, L.P.
|
34
|
2004
|
Long-Term
Compensation Awards
|
|||||||||||||||||||
Annual
Compensation
|
Securities
|
||||||||||||||||||
Other
Annual
|
Underlying
|
All
Other
|
|||||||||||||||||
Name
and
|
Salary
|
Bonus
|
Compensation
|
Options/SARs
|
Compensation
|
||||||||||||||
Principal
Position
|
Year
|
$
|
$
|
$
|
#
|
$
|
|||||||||||||
Michael
Garin
|
2005
|
625,000
|
950,000
|
--
|
30,000
|
20,019(8)
|
|
||||||||||||
Chief
Executive Officer (1)
|
2004
|
572,917
|
825,000
|
--
|
160,000
|
17,359(8)
|
|
||||||||||||
2003
|
--
|
--
|
--
|
--
|
--
|
||||||||||||||
|
|
|
|
||||||||||||||||
Frederic
T. Klinkhammer
|
2005
|
142,628
|
166,666
|
--
|
--
|
15,222(8)
|
|
||||||||||||
Vice
Chairman (2)
|
2004
|
625,000
|
--
|
--
|
--
|
19,243(8)
|
|
||||||||||||
2003
|
625,000
|
625,000
|
16,515(6)
|
|
40,000
|
1,017,620(9)
|
|
||||||||||||
|
|
|
|
|
|||||||||||||||
Robert
E. Burke
|
2005
|
328,440
|
184,257
|
76,363(7)
|
|
15,000
|
5,913(8)
|
|
|||||||||||
President
and Chief Operating
|
2004
|
326,493
|
425,196
|
76,182(7)
|
|
--
|
8,439(8)
|
|
|||||||||||
Officer
(3)
|
2003
|
293,010
|
271,528
|
68,369(7)
|
|
80,000
|
6,703(8)
|
|
|||||||||||
|
|
|
|
|
|||||||||||||||
Wallace
Macmillan
|
2005
|
355,596
|
163,482
|
--
|
10,000
|
4,865(8)
|
|
||||||||||||
Chief
Financial Officer and
|
2004
|
326,493
|
195,174
|
--
|
20,000
|
6,884(8)
|
|
||||||||||||
Vice
President - Finance(4)
|
2003
|
220,365
|
--
|
--
|
20,000
|
6,020(8)
|
|
||||||||||||
|
|
|
|
||||||||||||||||
Marina
Williams
|
2005
|
364,933
|
167,674
|
--
|
15,000
|
5,602(8)
|
|
||||||||||||
Executive
Vice President (5)
|
2004
|
41,759
|
42.238
|
--
|
20,000
|
222(8)
|
|
||||||||||||
2003
|
--
|
--
|
--
|
--
|
--
|
(1)
|
Became
Chief Executive Officer on February 2,
2004.
|
(2)
|
Retired
on March 22, 2005 in connection with expiration of his employment
agreement after having served as Vice-Chairman since February 2,
2004;
previously Vice Chairman and Chief Executive Officer since March
2003 and
Chief Executive Officer and President since March
1999.
|
(3)
|
Became
President and Chief Operating Officer in March 2003; previously Vice
President and Chief Operating Officer since July
2001.
|
(4)
|
Became
Chief Financial Officer and Vice President - Finance in March 2003.
|
(5)
|
Became
Executive Vice President on November 22,
2004.
|
(6)
|
Represents
an expatriate allowance.
|
(7)
|
Represents
a housing allowance.
|
(8)
|
Represents
life and health insurance benefits paid by the
Company.
|
(9)
|
Long-Term
Compensation included a $1,000,000 special long-term incentive bonus
granted to Mr. Klinkhammer pursuant to his employment agreement,
which
provided that if the fair market value of the Company’s Class A Common
Stock on December 31, 2003 was greater that $8.125 per share (the
split-adjusted trading price on March 22, 1999) and the percentage
increase in such share price was greater than the percentage increase
in
the NASDAQ composite average during the period from March 22, 1999
to
December 31, 2003, he would be entitled to such bonus. In addition,
he
received $17,620 in life and health insurance benefits paid by the
Company.
|
Individual
Grants
|
|||||||||||||||||||
Number
of Securities Underlying
|
Percent
of Total Options Granted to Employees in
|
Exercise
or Base
|
Potential
Realizable Value at Assumed Annual Rates of Stock Price Appreciation
For
Option Term
|
||||||||||||||||
Options
|
Fiscal
|
Price
|
Expiration
|
5%
|
10%
|
||||||||||||||
Name
|
Granted
|
Year
|
($/sh)
(1)
|
Date
(2)
|
($)
|
($)
|
|||||||||||||
Michael
Garin
|
30,000
|
15.42%
|
|
|
$44.50
|
6/1/15
|
|
$948,303
|
|
$2,473,911
|
|||||||||
|
|
|
|
|
|
||||||||||||||
Robert
E. Burke
|
15,000
|
7.71%
|
|
|
$44.50
|
6/1/15
|
|
$474,152
|
|
$1,236,955
|
|||||||||
|
|
|
|
|
|
||||||||||||||
Wallace
Macmillan
|
10,000
|
5.14%
|
|
|
$44.50
|
6/1/15
|
|
$316,101
|
|
$824,637
|
|||||||||
|
|
|
|
|
|
||||||||||||||
Marina
Williams
|
15,000
|
7.71%
|
|
|
$44.50
|
6/1/15
|
|
$474,152
|
|
$1,236,955
|
(1)
|
The
exercise price is set by the Compensation Committee, but may be not
less
than the fair market value of the Common Stock on the date of grant
of the
option. Options for the Named Executive Officers were granted on
June 2,
2005.
|
(2)
|
All
options granted to the Named Executive Officers will vest in four
equal
installments on each of the first four anniversaries of the date
of
grant.
|
Name
|
Shares
Acquired On Exercise (#)
|
Value
Realized ($)
|
Number
of Securities Underlying Unexercised Options at Fiscal Year-end
(#)
Exercisable/Unexercisable
|
Value
of Unexercised In-the-Money Options at Fiscal Year-End
($)(1)
Exercisable/Unexercisable
|
||||
Michael
Garin
|
0
|
0
|
40,000/150,000
|
$1,536,400/5,011,200
|
||||
Frederic
T. Klinkhammer
|
486,000
|
$20,530,912
|
800/13,200
|
$38,028/627,462
|
||||
Robert
E. Burke (2)
|
0
|
0
|
173,600/41,400
|
$9,239,376/1,455,927
|
||||
Wallace
Macmillan
|
0
|
0
|
20,000/30,000
|
$894,171/969,929
|
||||
Marina
Williams
|
0
|
0
|
6,600/28,400
|
$165,600/537,340
|
(1)
|
Fair
market value of securities underlying the options at fiscal year
end minus
the exercise price of the options.
|
(2)
|
On
March 3, 2006, Robert E. Burke exercised 25,000 options with an exercise
price of $2.128 per share, realizing a gain of $1,561,800 based on
an
average sale price on that date of $64.61 per
share.
|
Submitted
by
|
|
ALFRED
W. LANGER
|
|
CHARLES
R. FRANK, JR.
|
|
ANN
MATHER
|
·
|
rewarding
executives for their contributions based on one-year corporate operational
targets and implementation of longer term strategic goals;
|
·
|
balancing
salary and bonus compensation with long-term incentives to reinforce
achievement of annual corporate targets and strategic goals of the
Company; and
|
·
|
aligning
the interests of the Company’s executive officers to those of the
Company’s shareholders through equity-based compensation in order to
enhance shareholder value over
time.
|
·
|
The
Company raised approximately $700 million in a simultaneous offering
of
Euro 370 million in debt and more than $200 million in equity and
completed the purchase of substantially all of the interests in the
TV
Nova (Czech Republic) group.
|
·
|
The
Company reported Segment EBITDA*
of
$157.9 million for the year ended December 31, 2005, a 113% increase
over Segment EBITDA*
for the year ended December 31, 2004.
|
·
|
The
Company reported consolidated net revenues of $401 million for the
year ended December 31, 2005, a 120% increase over consolidated net
revenues for the year ended December 31,
2004.
|
·
|
The
dramatic improvement in the Company’s results reflects both the successful
management of the acquisition of the TV Nova (Czech Republic) group
and
the continued strong performance of the original stations of the
Company,
particularly in Romania and Ukraine.
|
·
|
Since
the beginning of 2005, the Company has increased its ownership interest
in
the Romanian operations to 90% and has acquired a controlling interest
in
our Slovak Republic operations.
|
·
|
Mr.
Garin has implemented measures designed to improve corporate governance
and corporate communications and his active management of investor
relations resulted in additional analyst coverage of the Company.
|
* |
For
a quantitative reconciliation of these non-GAAP financial measures
to the
most directly comparable financial measurements in accordance with
GAAP,
see the Company’s Annual Report on Form 10-K -
10K/A Information
for the year ended December 31, 2005 which accompanies this Proxy
Statement.
|
Compensation
Committee
|
|
BRUCE
MAGGIN
|
|
HERBERT
GRANATH
|
|
ANN
MATHER
|
Central
European Media Enterprises Ltd.
|
$
|
4541.18
|
||
NASDAQ
Composite Index
|
$
|
113.07
|
||
Dow
Jones World Broadcasting Index (1)
|
$
|
78.37
|
(1)
|
This
index includes 20 companies, many of which are non-U.S. based.
Accordingly, the Company believes that the inclusion of this index
is
useful in understanding the stock performance of the Company compared
to
companies in the television broadcast and cable
industry.
|
Equity
Compensation Plan Information
|
||||||
(a)
|
(b)
|
(c)
|
||||
Plan
Category
|
Number
of Securities to be issued upon exercise of outstanding options,
warrants
and rights
|
Weighted
average exercise price of outstanding options, warrants and
rights
|
Number
of securities remaining available for future issuance under equity
compensation plans (excluding securities reflected in column
(a))
|
|||
Equity
compensation plans approved by security holders
|
1,118,275(1)
|
$22.23
|
1,392,088(2)
|
|||
Equity
compensation plans not approved by security holders
|
0(3)
|
--
|
1,000,000
|
|||
Total
|
1,118,275
|
$22.23
|
(1)
|
This
number consists of options outstanding at December 31, 2005 under
the
Company’s 1994 Stock Option Plan and under the Amended and Restated 1995
Stock Incentive Plan.
|
(2)
|
This
number includes the aggregate number of shares of Common Stock that
remains available for future issuance, at December 31, 2005 under
the
Company’s shareholder approved equity compensation plans, consisting of
1,392,088 shares available under the Amended and Restated 1995 Stock
Incentive Plan. The term of the 1994 Stock Option Plan expired on
July 11,
2004. Any option outstanding under the 1994 Stock Option Plan at
the time
of the termination of the Plan will remain outstanding until such
option
has been exercised or has expired in accordance with its
terms.
|
(3)
|
The
Company’s 1998 Stock Appreciation Rights Plan (the “SAR Plan”) allows the
Company to grant up to 1,000,000 SARs. The SARs are subject to
substantially the same general conditions as apply to options granted
under the Amended and Restated 1995 Stock Incentive Plan. When SARs
are
exercised, the grantee will receive in cash the amount by which the
Company’s stock price exceeds a base price fixed by the Compensation
Committee at the time of grant. There were no SARs outstanding at
December
31, 2005.
|
By
order of the Board of Directors,
|
||
/s/ Daniel Penn | ||
DANIEL
PENN
|
||
Secretary
|
1.
|
Review
and assess the adequacy of this Charter at least
annually.
|
2.
|
Review
all public announcements of financial results and quarterly and annual
financial statements and reports prior to any filing with the Securities
and Exchange Commission.
|
3.
|
Recommend
to the Board that the audited financial statements be included in
the
Company’s annual report on Form 10-K for filing with the Securities and
Exchange Commission.
|
4.
|
Approve
the appointment and compensation of the Company’s independent registered
public accounting firm prior to any engagement and recommend that
appointment to shareholders for
ratification.
|
5.
|
Review
all relationships the Company’s independent registered public accounting
firm have with the Company to determine their independence and obtain
and
review a report from the independent registered public accounting
firm
concerning its internal quality control procedures; any material
issues
raised by the most recent internal quality-control review, or peer
review,
of the firm, or by any inquiry or investigation by governmental or
professional authorities, within the preceding five years, respecting
one
or more independent audits carried out by the firm, and any steps
taken to
deal with any such issues. The Company’s independent registered public
accounting firm shall annually provide to the Audit Committee a written
statement delineating all such
matters.
|
6.
|
Review
the annual audit plan of the Company’s independent registered public
accounting firm and evaluate its
performance.
|
7.
|
Review
the experience and qualifications of the senior members of the team
of the
Company’s independent registered public accounting firm and of the senior
internal corporate accounting and financial reporting
staff.
|
8.
|
Obtain
and review a report from the Company’s independent registered public
accounting firm at least annually as to (a) all critical accounting
policies to be used, (b) all alternative treatments of financial
information within generally accepted accounting principles that
have been
discussed with management of the Company, the ramifications of the
use of
such alternative disclosures and treatments and the treatment preferred
by
the Company’s independent registered public accounting firm , and (c)
other material written communications between the Company’s independent
registered public accounting firm and management of the Company,
including
management letters and schedules of unadjusted
differences.
|
9.
|
Require
the rotation of the lead (and coordinating or reviewing) audit partner
on
a regular basis in accordance with the requirements of the Exchange
Act.
|
10.
|
Review
the Company’s hiring of employees or former employees of the Company’s
independent registered public accounting firm who participated in
any
capacity in the audits of the
Company.
|
11.
|
Consult
with the Company’s independent registered public accounting firm
concerning the completeness and accuracy of the Company’s financial
statements.
|
12.
|
Review
with the Company’s independent registered public accounting firm and
internal accounting staff the adequacy of the Company’s system of internal
controls and disclosure controls and procedures, including computerized
information system controls and security, and any related significant
findings and recommendations of the Company’s independent registered
public accounting firm, together with management’s responses thereto.
|
13.
|
Consult
with the Company’s independent registered public accounting firm as
regards to the Company’s accounting principles as applied in its financial
statements and reporting.
|
14.
|
Review
any significant judgments made in management’s preparation of the
financial statements and the view of the Company’s independent registered
public accounting firm as to the appropriateness of such
judgments.
|
15.
|
Review
any significant difficulties encountered during the course of the
audit or
review, including any restrictions on the scope of work of the Company’s
independent registered public accounting firm or access to reviewed
information.
|
16.
|
Review
any disagreements between management and the Company’s independent
registered public accounting firm in connection with any public
announcements of financial results and quarterly and annual financial
statements and reports.
|
17.
|
Review
changes to the Company’s accounting principles as recommended by the
Company’s independent registered public accounting firm or
management.
|
18.
|
Review
periodically with the Company’s management, general counsel and the
Company’s independent registered public accounting firm, legal and
regulatory matters and accounting initiatives that could have a
significant effect on the Company’s financial
statements.
|
19.
|
Discuss
with management and the Company’s independent registered public accounting
firm the effect of unconsolidated subsidiaries and the corporate
ownership
structure, as well as of any off-balance sheet finance or special
purpose
vehicles, on the Company’s financial
statements.
|
20.
|
Review
existing policies concerning related party transactions and conflicts
of
interest between Board members or senior management, on the one hand,
and
the Company, on the other hand and recommend any changes to such
policies.
|
21.
|
Establish
procedures for (a) the receipt, retention, and treatment of complaints
received by the Company regarding accounting, internal accounting
controls, or auditing matters, and (b) the confidential, anonymous
submission by employees of the Company of concerns regarding questionable
accounting or auditing matters.
|
22.
|
Review
the Company’s policies with respect to risk assessment and risk
management.
|
23.
|
Participate
in an annual evaluation of the Audit
Committee.
|
24.
|
Investigate
any other matter brought to its attention within the scope of its
duties
that it deems appropriate for
investigation.
|
·
|
to
establish the criteria and minimum qualifications for Board membership
and
to publish these criteria and qualifications in accordance with applicable
rules and regulations in the Company’s proxy statement for its annual
meeting;
|
·
|
to
administer a process for identifying and evaluating nominees for
election
to the Board, consider and review candidates recommended by shareholders,
establish the procedures by which such shareholder candidates will
be
considered by the Committee and publish a description of this process
and
these procedures in accordance with applicable rules and regulations
in
the Company’s proxy statement for its annual meeting;
|
·
|
to
administer a process for security holders to send shareholder proposals
and other communications to the Board or management;
|
·
|
to
conduct the appropriate and necessary inquiries into the backgrounds
and
qualifications of possible
candidates;
|
·
|
to
advise on changes in Board
compensation;
|
·
|
to
make recommendations on the structure of Board meetings and the Company’s
processes for providing information to the members of the
Board;
|
·
|
to
make recommendations on orientation and continuing education programs
for
directors;
|
·
|
to
consider matters of corporate governance of the Company and to review
compliance with its corporate governance principles and policies,
including its Insider Trading Policy and it’s Code of Conduct and Ethics
(and publish such policies to the extent required by applicable NASDAQ
listing requirements and rules adopted by the U.S. Securities and
Exchange
Commission);
|
·
|
to
make recommendations on and administer policies in respect of the
resignation or retirement of directors;
|
·
|
to
determine that the Chairman of the Committee or another director
preside
over executive sessions of independent directors and publish the
identity
of such director in accordance with applicable rules and regulations
in
the Company’s proxy statement for its annual meeting;
and
|
·
|
to
review the adequacy of this charter and the performance of the Committee
in respect of this charter.
|
(a)
|
Qualifications
for Board Membership
|
1.
|
The
Committee may consider nominees for director of the Company submitted
in
writing to the Chairman of the Committee (along with the information
set
forth in (b) below), at CME Development Corporation, Aldwych House,
81
Aldwych, London WC2B 4HN United Kingdom c/o Company Secretary, which
are
submitted by executive officers of the Company, current directors
of the
Company, search firms engaged by the Committee, and by others in
its
discretion and, in the circumstances provided herein, shall consider
nominees for director proposed by a shareholder:
|
(a) |
the
shareholder shall have provided evidence that he/she/it has beneficially
owned at least 5% of the Company's Class A common stock for at least
one
year;
|
(b) |
the
information specified below with respect to the proposed nominee
shall
have been provided in writing to the Chairman of the Committee at
CME
Development Corporation, Aldwych House, 81 Aldwych, London WC2B 4HN
United
Kingdom c/o Company Secretary, at any time. However, if the nominee
is
proposed to be considered in connection with an annual meeting, the
information must be submitted at least 120 days prior to the date
of the
prior year's annual meeting proxy statement. Such information shall
include the name of the nominee, and such information with respect
to the
nominee as would be required under the rules and regulations of the
U.S.
Securities and Exchange Commission to be included in the Company's
proxy
statement if such proposed nominee were to be included therein. In
addition, the shareholder shall include a statement to the effect
that the
proposed nominee has no direct or indirect business conflict of interest
with the Company, and otherwise meets the Company's published minimum
criteria for consideration as a nominee for director of the Company.
|
2.
|
The
Committee shall consider proposals submitted by shareholders for
inclusion
in the Company's Annual General Meeting proxy statement if they are
submitted in writing to the Chairman of the Committee at CME Development
Corporation, Aldwych House, 81 Aldwych, London WC2B 4HN UK c/o the
Company
Secretary, at least 120 days prior to the date of the prior year's
annual
meeting proxy statement. Such proposals shall only be considered
for
inclusion if the submitting shareholder meets the qualifications
and
complies with the procedures provided in the proxy rules of the U.
S.
Securities and Exchange Commission. All such proposals shall be
accompanied by information with respect to the submitting shareholder
sufficient for the Company to determine whether such qualifications
are
met. The Committee will also evaluate any such proposal in light
of the
exclusionary rules promulgated from time to time by the U.S. Securities
and Exchange Commission.
|
3.
|
Any
other shareholder communications intended for management of the Company
or
the Board shall be submitted in writing to the Chairman of the Committee
at CME Development Corporation, Aldwych House, 81 Aldwych, London
WC2B 4HN
United Kingdom c/o the Company Secretary, who shall determine, in
his
discretion, considering the identity of the submitting shareholder
and the
materiality and appropriateness of the communication, whether, and
to whom
within the Company, to forward the
communication.
|
4.
|
The
Committee has sole authority to retain and terminate any search firm
to be
used to identify director candidates, including sole authority to
approve
the search firm’s fees and other retention
terms.
|
1. |
The
election of nine directors nominated by the Board of Directors to
serve
until the next Annual General Meeting of Shareholders:
|
o
|
FOR
all nominees listed below
|
o
|
WITHHOLD
AUTHORITY to vote for
|
|
(except
as indicated below)
|
the
nominees listed below
|
2.
|
The
adoption of the financial statements of the Company and the auditors’
report thereon for the Company’s fiscal year ended December 31,
2005.
|
o
FOR
|
o
AGAINST
|
o
ABSTAIN
|
3.
|
The
appointment of Deloitte & Touche LLP as the independent registered
public accounting firm of the Company for the fiscal year ended December
31, 2006 and the authorization of the Board of Directors, acting
through
the Audit Committee, to approve their
fee.
|
o
FOR
|
o
AGAINST
|
o
ABSTAIN
|